Author:
Strauss Kevin A.,Morton D. Holmes
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Chuang DT, Shih VE: Maple syrup urine disease (branched-chain ketoaciduria). In The Metabolic and Molecular Basis of Inherited Disease, edn 8. Edited by Scriver CR, Beaudet AL, Valle D, Sly WS. New York: McGraw-Hill; 2001.
2. Suryawan A, Hawes JW, Harris RA, et al.: A molecular model of human branched-chain amino acid metabolism. Am J Clin Nutr 1998, 68:72–81. Exhaustive study on human material shows distribution of whole body transamination and oxidation of BCAAs, and how these differ substantially from the rat.
3. Morton DH, Strauss KA, Robinson DL, et al.: Diagnosis and treatment of maple syrup disease: a study of 36 patients. Pediatrics 2002, 109:999–1008. This paper describes management and outcome of a large cohort of prospectively treated infants with classic disease, amounting to 219 patient years of follow-up. Principles of neonatal management are presented in detail.
4. Dodd PR, Williams SH, Gundlach AL, et al.: Glutamate and gamma-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves. J Neurochem 1992, 59:582–590.
5. DiGeorge AM, Rezvani I, Garibaldi LR, Schwartz M: Prospective study of maple-syrup-urine disease for the first four days of life. N Engl J Med 1982, 307:1492–1495.
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献